At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 30 enrolled
Drug / intervention
Intranasal Beclomethasone aerosol +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery Systems in Nasal Polyps
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's·interventional·Posted Nov 11, 2008·Updated Aug 28, 2017
In Brief
A Phase 2 clinical trial evaluating Intranasal Beclomethasone aerosol and Intranasal Beclomethasone spray for Nasal Polyps. Completed, enrolled 30 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if intranasal Beclomethasone delivered by aerosol or spray is more effective in treatment of nasal polyps.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNasal Polyps
CountriesCanada
Collaborators--
Timeline
Phase 2CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartNov 2006
First PostedNov 2008
Primary CompletionMar 2009
Study CompletionNov 2011
TodayJul 2026
First PostedNov 11, 2008
Enrollment StartNov 23, 2006
Primary CompletionMar 30, 2009
Study CompletionNov 30, 2011
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 17.6 years ago
Interventions
Intranasal Beclomethasone aerosoldrug
Beclomethasone aerosol intranasal, 100ug each nostril, twice daily for 6 months.
Intranasal Beclomethasone spraydrug
Beclomethasone spray intranasal, 100ug each nostril, twice daily for 6 months.